IntroductionModafinil is a wakefulness-promoting agent that has gained popularity as a cognitive enhancer and therapy for sleep disorders. Originally developed in France within the 1970s, it was authorised by the FDA in 1998 for the treatment of narcolepsy. Over time, its use has expanded past narcolepsy to include conditions equivalent
